questionText: To ask the Secretary of State for Health and Social Care, what steps his Department is taking to address the shortage of the drug pancrelipase for pancreatic exocrine insufficiency patients.
answerText: There are ongoing supply issues with pancrelipase, also known by the brand name Creon, capsules, used by patients with conditions such as cystic fibrosis and certain cancers including pancreatic and neuroendocrine cancer. The Department is continuing to w...
heading: Pancreatic Enzyme Replacement Therapy